Aditx Therapeutics Inc (ADTX)
Aditx Therapeutics Inc (ADTX) is a biotechnology company whose common stock trades on OTC Markets. This overview refers to the listed common equity security in the OTC Markets setting, rather than a fund, note, or other pooled instrument. The company is associated with biopharmaceutical research and development, with activity centered on immune-related diagnostics and therapeutic concepts. Its work has also been described in terms of molecular testing and other early-stage life sciences programs. Because this is a common stock listing, the security represents equity in the issuer and is subject to the risks typical of OTC-listed biotechnology shares.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-ADTX
|
$0.0021
|
-38.2% Downside
|
Overvalued
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 19, 2026
|
0.0x
|
0.0x
|
0.2x
|
2.419 K
|
2.07 M
|
181.0%
|
41.9%
|
-29.3
|
—
|
34.8%
|
